Rob Handfield Sees Indian Drug Production at Risk Due to COVID Outbreak
Rob Handfield, professor of operations and supply chain management, says drug production in India is at risk given the the current status of the COVID-19 outbreak.
“I’ve got to believe that the number of cases is going to hurt them,” said Handfield. “You’ve got to start testing people. … When you do find someone who’s sick, you’ve got to get people out of there. It’s going to interfere with operations. I don’t see how it won’t.”
Read more on BarChart.
This post was originally published on Poole Thought Leadership here.
Sign up for The SCM Professional Newsletter
Valuable supply chain research and the latest industry news, delivered free to your inbox.